tiprankstipranks
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Financial Statements

228 Followers

Rallybio Financial Overview

Rallybio's market cap is currently ―. The company's EPS TTM is $-1.879; its P/E ratio is -0.71; Rallybio is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -19.79M$ -21.11M$ -17.73M$ -18.41M$ -18.30M
EBITDA$ -19.75M$ -21.08M-$ -19.21M$ -19.16M
Net Income Common Stockholders$ -19.03M$ -20.24M$ -18.31M$ -18.63M$ -17.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 94.17M$ 109.93M$ 121.38M$ 137.84M$ 150.39M
Total Assets$ 99.36M$ 115.62M$ 133.19M$ 147.58M$ 161.97M
Total Debt$ 339.00K$ 392.00K$ 428.00K$ 479.00K$ 518.00K
Net Debt$ -93.84M$ -109.54M$ -120.96M$ -137.36M$ -149.87M
Total Liabilities$ 10.20M$ 9.44M$ 9.61M$ 8.32M$ 7.12M
Stockholders Equity$ 89.16M$ 106.18M$ 123.58M$ 139.26M$ 155.20M
Cash Flow-
Free Cash Flow$ -15.46M$ -11.66M-$ -13.38M$ -18.77M
Operating Cash Flow$ -15.46M$ -11.64M$ -16.47M$ -13.38M$ -18.77M
Investing Cash Flow$ 10.26M$ 16.91M$ 3.07M$ 6.21M$ 1.47M
Financing Cash Flow-$ 72.00K-$ 210.00K$ -139.00K
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis